1. Complete response in a patient with advanced melanoma following anti‐PD‐1 therapy is associated with a high frequency of melanoma‐infiltrating CXCR3+ resident memory CD8+ T cells and multiple chemokine pathways. (1st September 2021) Authors: Dousset, L.; Martins, C.; Jacquemin, C.; Amico, S.; Schatton, T.; Boniface, K.; Seneschal, J. Journal: British journal of dermatology Issue: Volume 185:Number 3(2021) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Complete response in a patient with advanced melanoma following anti‐PD‐1 therapy is associated with a high frequency of melanoma‐infiltrating CXCR3+ resident memory CD8+ T cells and multiple chemokine pathways. (14th June 2021) Authors: Dousset, L.; Martins, C.; Jacquemin, C.; Amico, S.; Schatton, T.; Boniface, K.; Seneschal, J. Journal: British journal of dermatology Issue: Volume 185:Number 3(2021) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1596 Radiotherapy and Ipilimumab as first-line immunotherapy: A comparative study on 63 patients. (April 2019) Authors: Benziane, N.; Atallah, V.; Amestoy, F.; Gerard, E.; Leduc, N.; Huchet, A.; Barry, M. Beylot; Dupin, C.; Prey, S.; Dousset, L.; Ouabrache, N.; Martin, M.; Gillon, P.; Dutriaux, C.; Trouette, R.; Vendrely, V. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Genomic and viral findings in two different primary Merkel cell carcinomas in a 76‐year‐old woman. (30th March 2016) Authors: Dousset, L.; Dutriaux, C.; Taïeb, A.; Chibon, F.; Foulongne, V.; Frouin, E.; Jullié, M.L.; Jouary, T. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 1(2017:Jan.) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing. (1st November 2020) Authors: Le Cleach, L.; Dousset, L.; Assier, H.; Fourati, S.; Barbarot, S.; Boulard, C.; Bourseau Quetier, C.; Cambon, L.; Cazanave, C; Colin, A.; Kostrzewa, E.; Lesort, C.; Levy Roy, A.; Lombart, F.; Marco‐Bonnet, J.; Monfort, J.‐B.; Samimi, M.; Tardieu, M.; Wolkenstein, P.; Sbidian, E. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing. (9th August 2020) Authors: Le Cleach, L.; Dousset, L.; Assier, H.; Fourati, S.; Barbarot, S.; Boulard, C.; Bourseau Quetier, C.; Cambon, L.; Cazanave, C; Colin, A.; Kostrzewa, E.; Lesort, C.; Levy Roy, A.; Lombart, F.; Marco‐Bonnet, J.; Monfort, J.‐B.; Samimi, M.; Tardieu, M.; Wolkenstein, P.; Sbidian, E. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology. (12th May 2021) Authors: Guelimi, R.; Salle, R.; Dousset, L.; Assier, H.; Fourati, S.; Bhujoo, Z.; Barbarot, S.; Boulard, C.; Cazanave, C.; Colin, A.; Kostrzewa, E.; Lesort, C.; Levy Roy, A.; Lombart, F.; Marco Bonnet, J.; Marty, L.; Monfort, J.B.; Riffaud, L.; Samimi, M.; Tardieu, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 9(2021) Page Start: e539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0088 Immune-related adverse events of cancer immunotherapy – when inflammatory side effects are associated with survival: a single-centre prospective cohort study. (12th June 2018) Authors: Kostine, M.; Mauric, E.; Rouxel, L.; Barnetche, T.; Veillon, R.; Martin, F.; Dutriaux, C.; Dousset, L.; Pham-Ledard, A.; Prey, S.; Beylot-Barry, M.; Daste, A.; Gross-Goupil, M.; Lallier, J.; Ravaud, A.; Forcade, E.; Bannwarth, B.; Truchetet, M.-E.; Richez, C.; Mehsen-Cetre, N. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-0835: Contact Radiotherapy For Lentigo Maligna And Lentigo Maligna Melanoma: A Cohort Of 61 Cases. (April 2018) Authors: Lamoureux, A.; Ouhabrache, N.; Coulibaly, S.; Dousset, L.; Gerard, E.; Dutriaux, C.; Pham-Ledard, A.; Cogrel, O.; Trouette, R.; Beylot-Barry, M.; Vendrely, V. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0540 ONE-YEAR OUTCOMES AFTER RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FROM CHECKPOINT INHIBITORS. (2nd June 2020) Authors: Berard, E.; Barnetche, T.; Rouxel, L.; Dutriaux, C.; Dousset, L.; Prey, S.; Beylot-Barry, M.; Seneschal, J.; Veillon, R.; Vergnenegre, C.; Daste, A.; Domblides, C.; Sionneau, B.; Gross-Goupil, M.; Ravaud, A.; Forcade, E.; Schaeverbeke, T.; Kostine, M. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗